首页> 外文期刊>Polish journal of veterinary sciences >Development of a recombinant NP protein based indirect ELISA for the detection of antibodies against Newcastle disease virus and differentiation of infected or recombinant vaccine immunized chickens
【24h】

Development of a recombinant NP protein based indirect ELISA for the detection of antibodies against Newcastle disease virus and differentiation of infected or recombinant vaccine immunized chickens

机译:基于重组NP蛋白的间接ELISA检测对新城疫病毒的抗体和感染或重组疫苗免疫鸡的分化

获取原文
获取原文并翻译 | 示例
       

摘要

Newcastle disease (ND) is a highly contagious and economically important disease in the poultry industry caused by avian avulavirus-1, historically known as Newcastle disease virus (NDV). Control of ND primarily relies on prophylactic vaccination of flocks, and many vaccines are available on the market, both conventional and more recently introduced new generation recombinant types. To assess the protection level achieved by vaccination ELISA tests are typically used, they also are to track an infection with field strains in non-vaccinated flocks. Special modifications of ELISA can be used as a screening tool to detect infection in flocks vaccinated with new generation vaccines. In this study, we have developed an ELISA test for the detection of antibodies against the nucleoprotein (NP) of NDV and for differentiation of chickens vaccinated with commercial and prototype in-house recombinant vector vaccines from those infected with field NDV strains. The NP gene of LaSota NDV strain expressed in a baculovirus vector was used as a coating antigen in the ELISA. The developed test was optimized, validated and compared to other serological tests. The sensitivity, specificity and accuracy of recombinant NP protein-based ELISA were respectively 96.1%, 96.3%, and 96.2%. Inter-rater (kappa) agreement between the NP-ELISA and the gold standard HI test was calculated to be 0.995. In our comparisons, commercially available ELISA tests revealed different specificities ranging from 95.5-100% and sensitivities at variance, ranging from 90.1 to 99.0%. A high level of maternally derived antibodies was measured in the serum of 1-day-old broilers in the NP-ELISA assay. These antibodies had disappeared and were undetected at 3, 5 and 6 weeks post-vaccination but birds became positive again at 2 weeks after control infection with a velogenic NDV strain. In SPF chickens, antibodies against NP protein were detected only after a challenge. The recombinant NP protein-based ELISA test is sensitive, specific and accurate when compared to the gold standard HI test and commercially available kits. Moreover, the method could be also used for the differentiation between vaccinated and infected birds.
机译:Newcastle疾病(ND)是由禽Avulavirus-1引起的家禽行业的高度传染性和经济上重要的疾病,历史上称为新城疫病毒(NDV)。 ND的控制主要依赖于预防羊群的疫苗接种,并且许多疫苗可在市场上提供,常规和最近引入的新一代重组类型。为了评估疫苗接种疫苗的保护水平,通常使用ELISA测试,它们还在追踪未疫苗的羊群中的田间菌株的感染。 ELISA的特殊修饰可用作筛选工具,以检测与新一代疫苗接种疫苗的羊群中的感染。在本研究中,我们开发了一种ELISA测试,用于检测抗NDV核蛋白(NP)的抗体,并用于与来自感染田NDV菌株感染的商业和原型重组载体疫苗接种的鸡的分化。在杆状病毒载体中表达的Lasota NDV菌株的NP基因用作ELISA中的涂层抗原。显影测试得到了优化,验证并与其他血清学测试进行了验证。重组NP蛋白基ELISA的敏感性,特异性和准确性分别为96.1%,96.3%和96.2%。 NP-ELISA和黄金标准HI测试之间的帧间(KAPPA)协议计算为0.995。在我们的比较中,市售的ELISA测试显示出不同的特异性,从95.5-100%和方差的敏感性,范围为90.1至99.0%。在NP-ELISA测定中的1天龄肉鸡的血清中测量了高水平的母体衍生的抗体。这些抗体在接种后3,5和6周未被检测到,但在用麝香基NDV菌株进行控制感染后2周再次成为阳性。在SPF鸡中,仅在挑战后发现针对NP蛋白的抗体。与金标准的HI试验和市售试剂盒相比,重组NP基于基于NP蛋白的ELISA测试是敏感的,具体和准确的。此外,该方法也可用于接种和感染鸟类之间的分化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号